Lamond Capital Partners as of Dec. 31, 2015
Portfolio Holdings for Lamond Capital Partners
Lamond Capital Partners holds 9 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amgen (AMGN) | 25.9 | $35M | 250k | 138.32 | |
| Oracle Corporation (ORCL) | 13.5 | $18M | 500k | 36.12 | |
| Ocular Therapeutix (OCUL) | 13.0 | $17M | 1.2M | 14.06 | |
| Alexion Pharmaceuticals | 11.7 | $16M | 100k | 156.39 | |
| Abbvie (ABBV) | 10.2 | $14M | 250k | 54.41 | |
| Gw Pharmaceuticals Plc ads | 8.2 | $11M | 120k | 91.37 | |
| BioMarin Pharmaceutical (BMRN) | 7.9 | $11M | 100k | 105.32 | |
| Cypress Semiconductor Corporation | 7.0 | $9.4M | 1.1M | 8.52 | |
| Kite Pharma | 2.6 | $3.5M | 63k | 55.68 |
